Edward J. Ludwig - May 4, 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
Director
Signature
/s/ Susan Thompson, Attorney-in-Fact
Stock symbol
BSX
Transactions as of
May 4, 2023
Transactions value $
$0
Form type
4
Date filed
5/5/2023, 04:27 PM
Previous filing
Nov 21, 2022
Next filing
May 19, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Deferred Stock Units Award $0 +3.95K +10.54% $0.00 41.4K May 4, 2023 Common Stock 3.95K Direct F1, F2, F3
transaction BSX Deferred Stock Units Award $0 +2.98K +7.21% $0.00 44.4K May 4, 2023 Common Stock 2.98K Direct F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 Reflects a value of $205,000 divided by the closing price of common stock on the date of grant.
F3 Annual equity award in the form of deferred stock units vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Director service in accordance with the Company's Non-Employee Director Deferred Compensation Plan.
F4 Reflects a value of $155,000 divided by the closing price of common stock on the date of grant.
F5 Deferred stock units were granted in lieu of quarterly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan.